Now, new research is pointing to an unexpected ally in the fight against nicotine addiction. You guess it, it’s psilocybin<\/a><\/strong>, the active compound found in magic mushrooms.<\/p>\n\n\n\n A recent clinical trial from Johns Hopkins University<\/strong><\/a> suggests that psilocybin-assisted therapy could dramatically improve smoking cessation outcomes \u2014 offering a fresh and promising direction for addiction treatment.<\/p>\n\n\n\n Much of the recent attention around psychedelics has focused on their potential for treating depression, anxiety, and post-traumatic stress disorder. This new study expands that conversation, highlighting the role these compounds could play in addressing addiction.<\/p>\n\n\n\n The trial, published in JAMA Network Open<\/em>, compared nicotine patches<\/strong> (a standard smoking cessation tool) <\/em>with a single high dose of psilocybin<\/strong>.<\/p>\n\n\n\n After six months, the difference between the two groups was striking.<\/p>\n\n\n\n Participants who received psilocybin had more than six times greater odds of remaining abstinent from cigarettes<\/strong> compared to those using nicotine replacement therapy.<\/p>\n\n\n\n \u201cI was surprised by the sheer magnitude of the effect,\u201d <\/em>said Matthew Johnson, the study\u2019s lead author and professor of psychiatry at Johns Hopkins.<\/p>\n\n\n\n For a field that has seen slow progress in developing new treatments, results like these are generating genuine excitement.<\/p>\n\n\n\n The trial involved 82 current smokers<\/strong>, randomly assigned to one of two groups. One group received nicotine patches, while the other received psilocybin.<\/p>\n\n\n\n All participants took part in cognitive behavioral therapy (CBT) for smoking cessation over 13 weeks<\/strong>, ensuring that psychological support was a central part of the process.<\/p>\n\n\n\n The psilocybin sessions followed a structured format commonly used in psychedelic research. Participants were supported by trained facilitators, designed to help them feel safe and prepared.<\/p>\n\n\n\n During the experience, they lay in a comfortable setting, wore eye shades<\/strong>, and listened to soft music<\/a><\/strong>. The experience itself was described as \u201cself-directed,\u201d<\/em><\/strong> allowing individuals to navigate their thoughts and emotions in their own way.<\/p>\n\n\n\n Because psilocybin\u2019s effects are so noticeable, participants knew whether they had received the compound. While this can influence results, Johnson noted that maintaining a traditional placebo setup in psychedelic studies presents unique challenges.<\/p>\n\n\n\n At the six-month follow-up, 17 participants in the psilocybin group had successfully quit smoking<\/strong>, compared to just four in the nicotine patch group<\/strong>.<\/p>\n\n\n\n These numbers stand out, especially when compared to existing treatments.<\/p>\n\n\n\n Currently, there are seven medications available for smoking cessation<\/strong>, most of which rely on nicotine replacement methods like gums, lozenges, and patches. Two additional medications \u2014 varenicline<\/strong> and bupropion<\/strong> \u2014 offer alternative approaches.<\/p>\n\n\n\n Even with these tools, success rates remain limited.<\/p>\n\n\n\n According to Megan Piper, director of the UW Center for Tobacco Research and Intervention, long-term quit rates typically fall between 20% and 30% per attempt<\/strong> when medication is combined with counseling.<\/p>\n\n\n\n \u201cThat still means 70% of people are returning to smoking. So how do we help those folks?\u201d <\/em>she says.<\/p>\n\n\n\n This is where psilocybin\u2019s potential becomes especially significant.<\/p>\n\n\n\n One reason these findings are so encouraging is that psilocybin works in a fundamentally different way from traditional smoking cessation treatments.<\/p>\n\n\n\n Most existing therapies focus on replacing nicotine or reducing withdrawal symptoms<\/strong>. Psilocybin does neither.<\/p>\n\n\n\n Instead, it interacts with the brain\u2019s serotonin system and appears to influence neuroplasticity<\/strong>. This is the brain\u2019s ability to reorganize and form new patterns.<\/p>\n\n\n\n Dr. Brian Barnett, an addiction psychiatrist at the Cleveland Clinic Lerner College of Medicine, described the research as \u201ccutting-edge.\u201d<\/em><\/p>\n\n\n\n \u201cSmoking is still a massive public health problem,\u201d <\/em>he said.<\/p>\n\n\n\n He also noted that psilocybin represents \u201ca very different treatment approach from just trying to replace or sort of mimic the drug that’s being misused.\u201d<\/em><\/p>\n\n\n\n Barnett believes the therapy component is just as important as the compound itself.<\/p>\n\n\n\n \u201cIt\u2019s not the drug by itself here,\u201d <\/em>he says. \u201cIt\u2019s really harnessing the neuroplastic and learning effects that happen after the [drug] exposure.\u201d<\/em><\/p>\n\n\n\n Researchers are still working to fully understand why psilocybin appears to be so effective in this context. Early clues point toward the way it changes brain activity and perception.<\/p>\n\n\n\n \u201cWe already know that when people are on a compound like psilocybin, the brain is communicating with itself in very different ways,\u201d <\/em>Johnson explained.<\/p>\n\n\n\n Brain imaging data from the study is still being analyzed, but anecdotal reports from participants offer valuable insight.<\/p>\n\n\n\n Many described a shift in perspective<\/strong>. A feeling of stepping outside habitual patterns and seeing their behavior more clearly.<\/p>\n\n\n\n \u201cRather than falling into the same stories, these same patterns, it seems that things are shaken up and they can step outside of that and try something different,\u201d <\/em>Johnson said.<\/p>\n\n\n\n This ability to interrupt deeply ingrained habits may be key to addressing addiction, which often operates through repeated behavioral loops.<\/p>\n\n\n\n This study didn\u2019t appear out of nowhere. It builds on earlier work by Johnson and his team, including a smaller trial conducted more than ten years ago that also showed promising results.<\/p>\n\n\n\n Together, these findings have been strong enough to attract support from the National Institutes of Health<\/strong>, which is now funding a larger, ongoing study that includes a placebo group.<\/p>\n\n\n\n While replication in larger and more diverse populations is still needed, experts see the current results as a meaningful step forward.<\/p>\n\n\n\n \u201cIt\u2019s been 20 years since we\u2019ve had a new medication to help people quit smoking,\u201d <\/em>Piper said. \u201cWe need something novel, and this is definitely a novel approach.\u201d<\/em><\/p>\n\n\n\n Research into psychedelics and addiction is still in its early stages, but interest is expanding.<\/p>\n\n\n\n Studies exploring psilocybin for alcohol dependence<\/a><\/strong> have shown promising early results, and clinical trials are ongoing. At the same time, compounds like ibogaine<\/a><\/strong> are being investigated for their potential role in treating opioid use disorder.<\/p>\n\n\n\n Despite this growing interest, much of the funding and attention in psychedelic science has focused on mental health conditions such as depression and anxiety.<\/p>\n\n\n\n This new research highlights the importance of expanding that focus.<\/p>\n\n\n\n For those working in public health and addiction treatment, the implications of this study are hard to ignore. Smoking continues to affect millions of people worldwide, and existing treatments leave a large portion of individuals struggling to quit.<\/p>\n\n\n\n The idea that a single psilocybin session, combined with therapeutic support<\/strong>, could significantly improve outcomes represents a major shift in how addiction might be approached in the future. While more research is needed before this treatment becomes widely available, the direction is clear.<\/p>\n\n\n\n Psilocybin may soon be part of an entirely new way of understanding and treating addiction.<\/p>\n\n\n\n And for many people trying to quit smoking, that is genuinely good news.<\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" A groundbreaking new trial has found that smokers were more than six times as likely to quit after having psilocybin therapy. Discover the whole study, and what it means, here. <\/p>","protected":false},"author":4,"featured_media":270287,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[88],"tags":[],"topics":[],"class_list":["post-270261","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-psychedelic-studies"],"_links":{"self":[{"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/posts\/270261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/comments?post=270261"}],"version-history":[{"count":3,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/posts\/270261\/revisions"}],"predecessor-version":[{"id":270289,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/posts\/270261\/revisions\/270289"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/media\/270287"}],"wp:attachment":[{"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/media?parent=270261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/categories?post=270261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/tags?post=270261"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/www.wholecelium.com\/sv\/wp-json\/wp\/v2\/topics?post=270261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"https:\/\/www.wholecelium.com\/wp-content\/uploads\/cigarette-ash-addiction.jpg\")
A Breakthrough Moment in Psychedelic Research<\/h3>\n\n\n\n
How the Study Worked<\/h4>\n\n\n\n
![\"\"](\"https:\/\/www.wholecelium.com\/wp-content\/uploads\/magic-mushrooms-6.jpg\")
The Results: A Clear Difference<\/h2>\n\n\n\n
A Completely Different Approach to Addiction<\/h3>\n\n\n\n
![\"\"](\"https:\/\/www.wholecelium.com\/wp-content\/uploads\/smoking-gif.gif\")
<\/figure>\n\n\n\nWhy Psilocybin May Help People Quit<\/h4>\n\n\n\n
Building on a Decade of Research<\/h5>\n\n\n\n
![\"\"](\"https:\/\/www.wholecelium.com\/wp-content\/uploads\/mushroom-gills-medicinal-3.jpg\")
Psychedelics and Addiction: A Growing Field<\/h3>\n\n\n\n
A Promising Shift for the Future<\/h4>\n\n\n\n
![\"\"](\"https:\/\/www.wholecelium.com\/wp-content\/uploads\/7-35.png\")
<\/figure>\n\n\n\n